EJBY, Denmark, Sept. 9, 2024 /PRNewswire/ — These days Scantox, along side its majority proprietor Impilo, finalized the purchase of Gentronix Ltd, a UK based totally GLP compliant genetic toxicology Word of honour Analysis Group (“CRO”).
Gentronix, now built-in into Scantox Crew, is definitely identified for its top of the range genetic toxicology products and services and powerful medical engagement, with an undisputed monitor document of serving a faithful and large world buyer bottom. With the purchase of Gentronix, Scantox’s provider platform expands considerably to satisfy consumer calls for as a marketplace CRO to aid pre-IND enabling research.
For 25 years, Gentronix has equipped genetic toxicology answers to the worldwide pharma, biotech and agrichem industries; enabling purchasers to optimize their building systems by way of enabling early id of genotoxic compounds and supporting late-stage building stages with GLP research. Gentronix offer a complete portfolio of screening and regulatory genotoxicity assays and products and services, now not least the OECD 488 Bulky Blue® Transgenic Rodent Mutation assay, as certainly one of most effective 3 world suppliers. Additional, Gentronix has experience and products and services inside perceptible and pores and skin toxicology endpoints.
Based in 1999 by way of Prof. Richard Walmsely, Gentronix is positioned throughout the North West UK on the Alderley Ground and employs alike to 70 staff upcoming a vital scale-up over the date 5 years.
“I am thrilled that Scantox Group has been able to partner up with Gentronix. Genetic toxicology is a missing link in our portfolio and frequently requested by our clients to become a one-stop-shop premier CRO partner. Gentronix´s service line, client base, high quality standards and not least people culture fits perfectly with our DNA. Our business plan is to continuously expand our service portfolio across all sites and add scientific excellence to the Group,” says Jeanet Løgsted, CEO of Scantox Crew.
Matt Tate, CEO of Gentronix, provides: “Becoming a part of Scantox Group is a fantastic next step for Gentronix, opening up unique possibilities for us to offer an even greater service portfolio to our clients. As an organization we look forward to collaborating with our new colleagues and continuing to support the delivery of world-leading contract research services to our customers. There is a strong strategic rationale in teaming up with Scantox and we have identified multiple commercial synergies”.
Gentronix Ltd will proceed to perform below the flow corporate identify, increasing its provider providing inside specialist regulatory toxicology. With this acquisition the Scantox Crew will make use of greater than 400 population throughout seven Ecu websites providing first at school supremacy optimization, regulatory toxicology and CMC (Chemical, Production, Controls), method and analytical products and services.
Nicholas Hooge, Spouse at Impilo, concludes, “We are thrilled to welcome Gentronix into the Scantox group and see significant growth opportunities for the combined business going forward. 2024 is in many ways a transformational year for Scantox and this acquisition represents another important milestone in reaching Scantox’ strategic ambitions.”
For additional data, please touch:
Jeanet Løgsted, CEO of Scantox, [email protected]
Matt Tate, Managing Director of Gentronix, a part of Scantox Crew, [email protected]
Brand – https://mma.prnewswire.com/media/2494840/Scantox_Gentronix_Logo.jpg
